ATE498415T1 - Erzeugung gewebetechnologisch hergestellter weiblicher fortpflanzungsorgane - Google Patents

Erzeugung gewebetechnologisch hergestellter weiblicher fortpflanzungsorgane

Info

Publication number
ATE498415T1
ATE498415T1 AT02780711T AT02780711T ATE498415T1 AT E498415 T1 ATE498415 T1 AT E498415T1 AT 02780711 T AT02780711 T AT 02780711T AT 02780711 T AT02780711 T AT 02780711T AT E498415 T1 ATE498415 T1 AT E498415T1
Authority
AT
Austria
Prior art keywords
female reproductive
reproductive organs
tissue
generation
cells
Prior art date
Application number
AT02780711T
Other languages
German (de)
English (en)
Inventor
Anthony Atala
James Yoo
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Application granted granted Critical
Publication of ATE498415T1 publication Critical patent/ATE498415T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3679—Hollow organs, e.g. bladder, esophagus, urether, uterus, intestine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3826—Muscle cells, e.g. smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A61L27/3891—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types as distinct cell layers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1347—Smooth muscle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/24—Genital tract cells, non-germinal cells from gonads
    • C12N2502/243—Cells of the female genital tract, non-germinal ovarian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02780711T 2001-11-16 2002-11-15 Erzeugung gewebetechnologisch hergestellter weiblicher fortpflanzungsorgane ATE498415T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33150301P 2001-11-16 2001-11-16
PCT/US2002/036965 WO2003043675A1 (fr) 2001-11-16 2002-11-15 Creation d'organes reproducteurs feminins a partir de tissus

Publications (1)

Publication Number Publication Date
ATE498415T1 true ATE498415T1 (de) 2011-03-15

Family

ID=23294238

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02780711T ATE498415T1 (de) 2001-11-16 2002-11-15 Erzeugung gewebetechnologisch hergestellter weiblicher fortpflanzungsorgane

Country Status (12)

Country Link
US (3) US7806937B2 (fr)
EP (1) EP1448247B1 (fr)
JP (1) JP4065846B2 (fr)
KR (1) KR20050044498A (fr)
CN (2) CN1294996C (fr)
AT (1) ATE498415T1 (fr)
AU (1) AU2002343749B2 (fr)
BR (1) BR0214212A (fr)
CA (1) CA2467558C (fr)
DE (1) DE60239217D1 (fr)
HK (1) HK1077524A1 (fr)
WO (1) WO2003043675A1 (fr)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0214212A (pt) * 2001-11-16 2004-10-26 Childrens Medical Center Criação de órgãos reprodutores femininos construìdos por tecido
US20030180268A1 (en) * 2002-02-05 2003-09-25 Anthony Atala Tissue engineered construct for supplementing or replacing a damaged organ
EP1513927A4 (fr) * 2002-05-23 2007-02-28 Advanced Cell Tech Inc Creation de tissus histocompatibles par transplantation nucleaire
DE10333863A1 (de) * 2003-07-24 2005-02-17 Walles, Thorsten Dr. Med. Bioartifizielles, primär vaskularisiertes Testgewebe für pharmakologische Testverfahren, Verfahren zu dessen Herstellung und Testverfahren unter dessen Verwendung sowie Bioreaktor zur Durchführung der Verfahren
EP1550715A1 (fr) * 2003-12-30 2005-07-06 Bionethos Holding Gmbh Procédé pour la regénération de tissu
AU2004309083B2 (en) * 2003-12-30 2010-11-11 Augustinus Bader Tissue regeneration method
US20060199265A1 (en) * 2005-03-02 2006-09-07 Wolf Michael F Seeding implantable medical devices with cells
US7759120B2 (en) 2005-03-02 2010-07-20 Kps Bay Medical, Inc. Seeding implantable medical devices with cells
CA2618731C (fr) 2005-08-26 2021-12-28 Regents Of The University Of Minnesota Decellularisation et recellularisation d'organes et de tissus
US20100093066A1 (en) * 2005-08-26 2010-04-15 Regents Of The University Of Minnesota Decellularization and recellularization apparatuses and systems containing the same
US8096967B2 (en) * 2006-02-02 2012-01-17 Milan Radojicic Tissue engineered cerebrospinal fluid shunt
US8764697B2 (en) 2006-02-01 2014-07-01 Agathos Holdings Llc Systems and methods for an advanced medical device
WO2007095193A2 (fr) * 2006-02-10 2007-08-23 Tengion, Inc. Structures formant échafaudage destinées à une reconstruction et à une augmentation d'organe
US9555167B2 (en) * 2006-12-11 2017-01-31 3M Innovative Properties Company Biocompatible antimicrobial compositions
US20080200890A1 (en) * 2006-12-11 2008-08-21 3M Innovative Properties Company Antimicrobial disposable absorbent articles
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US10448989B2 (en) 2009-04-09 2019-10-22 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
US10238447B2 (en) 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US8926606B2 (en) * 2009-04-09 2015-01-06 Virginia Tech Intellectual Properties, Inc. Integration of very short electric pulses for minimally to noninvasive electroporation
US9283051B2 (en) 2008-04-29 2016-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US10245098B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
WO2009134876A1 (fr) * 2008-04-29 2009-11-05 Virginia Tech Intellectual Properties, Inc. Électroporation irréversible destinée à créer des échafaudages tissulaires
US8992517B2 (en) 2008-04-29 2015-03-31 Virginia Tech Intellectual Properties Inc. Irreversible electroporation to treat aberrant cell masses
US10272178B2 (en) 2008-04-29 2019-04-30 Virginia Tech Intellectual Properties Inc. Methods for blood-brain barrier disruption using electrical energy
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
US11272979B2 (en) 2008-04-29 2022-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
US8795264B2 (en) * 2008-07-01 2014-08-05 Ralph Zipper Method for decreasing the size and/or changing the shape of pelvic tissues
EP3693454A1 (fr) 2008-07-16 2020-08-12 Children's Medical Center Corporation Dispositif simulateur d'organe comportant des microcanaux et ses procédés d'utilisation et de fabrication
CN102387824B (zh) * 2008-12-24 2016-02-03 奥古斯蒂努斯·巴德 可植入的天然或合成的细胞生长支持支架用于制备植入物的用途
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
WO2010138919A2 (fr) 2009-05-28 2010-12-02 Angiodynamics, Inc. Système et méthode de synchronisation de l'apport d'énergie et du rythme cardiaque
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
US20110065809A1 (en) * 2009-09-15 2011-03-17 Medtronic, Inc. Polymerization of Multifunctional Azides, and Polymers Therefrom
CN101712946B (zh) * 2009-09-27 2013-02-27 南通大学附属医院 构建生殖结节器官培养尿道体外发育模型的方法
KR20130005285A (ko) * 2010-03-09 2013-01-15 텐젼, 인코포레이티드 세포 골격 구조물
MX343363B (es) 2010-09-01 2016-11-03 Regents Of The Univ Of Minnesota * Metodos para recelularizar un tejido o un organo para una transplantabilidad mejorada.
TW201219573A (en) * 2010-09-22 2012-05-16 Ct Hospitalier Universitaire Vaudois Anti-fibrotic response provided by fetal cells to implants and delivery systems
US20120089238A1 (en) 2010-10-06 2012-04-12 Hyun-Wook Kang Integrated organ and tissue printing methods, system and apparatus
EP2627274B1 (fr) 2010-10-13 2022-12-14 AngioDynamics, Inc. Système d'ablation électrique des tissus chez un patient
WO2012068071A2 (fr) * 2010-11-15 2012-05-24 Sanofi Pasteur Vaxdesign Corp. Modèles de co-culture urogénitale in vitro
KR102117921B1 (ko) 2011-02-28 2020-06-03 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 세포 배양 시스템
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
US9725687B2 (en) 2011-12-09 2017-08-08 President And Fellows Of Harvard College Integrated human organ-on-chip microphysiological systems
WO2013165256A1 (fr) 2012-04-30 2013-11-07 Laerdal Global Health As Modèle d'utérus post-partum
US9290738B2 (en) 2012-06-13 2016-03-22 Miromatrix Medical Inc. Methods of decellularizing bone
US9775864B2 (en) 2013-01-31 2017-10-03 Ams Research Corporation Vaginal laxity therapy utilizing cell-based bulking compositions
US9532901B2 (en) 2013-02-05 2017-01-03 Mor Research Applications Ltd. Fertility preservation device
CN105164250A (zh) 2013-03-15 2015-12-16 米罗马特里克斯医疗公司 灌注脱细胞化的肝脏在胰岛细胞再细胞化中的用途
WO2015013332A1 (fr) 2013-07-22 2015-01-29 President And Fellows Of Harvard College Ensemble cartouche microfluidique
WO2015138034A2 (fr) 2013-12-20 2015-09-17 President And Fellows Of Harvard College Dispositifs microfluidiques à faible cisaillement et leurs procédés d'utilisation et de fabrication
US10471254B2 (en) 2014-05-12 2019-11-12 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
AU2015289999B2 (en) 2014-07-14 2020-09-10 President And Fellows Of Harvard College Systems and methods for improved performance of fluidic and microfluidic systems
WO2016044421A1 (fr) * 2014-09-18 2016-03-24 National Health Research Institutes Cellules progénitrices, leur procédé de préparation et leurs utilisations
WO2016100325A1 (fr) 2014-12-15 2016-06-23 Virginia Tech Intellectual Properties, Inc. Dispositifs, systèmes et méthodes de surveillance en temps réel d'effets électrophysiologiques au cours d'un traitement tissulaire
US10479980B2 (en) 2015-01-30 2019-11-19 Northwestern University Artificial ovary
JP6494393B2 (ja) * 2015-04-21 2019-04-03 学校法人東京女子医科大学 子宮組織治療用細胞組成物及びその製造方法
RU2587723C1 (ru) * 2015-07-03 2016-06-20 Федеральное государственное бюджетное учреждение "Научный центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Усовершенствованная методика операции кольпопоэза из тазовой брюшины с лапароскопической ассистенцией
US10202569B2 (en) 2015-07-24 2019-02-12 President And Fellows Of Harvard College Radial microfluidic devices and methods of use
WO2018005939A1 (fr) 2016-07-01 2018-01-04 The Board Of Regents Of The University Of Texas System Procédés, appareils et systèmes destinés à créer des représentations tridimensionnelles présentant des caractéristiques géométriques et superficielles de lésions cérébrales
US11278643B2 (en) 2016-09-06 2022-03-22 Mayo Foundation For Medical Education And Research Use of resected liver serum for whole liver-engineering
CA3036378A1 (fr) 2016-09-13 2018-03-22 President And Fellows Of Harvard College Procedes se rapportant a un organe intestinal sur puce
US10905492B2 (en) 2016-11-17 2021-02-02 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
JP7031138B2 (ja) 2017-05-11 2022-03-08 株式会社リコー 脱細胞化組織の製造方法、及び脱細胞化組織の製造装置
CN109749980B (zh) * 2017-11-07 2022-03-25 深圳先进技术研究院 一种能够激活原始卵泡的3d打印人造卵巢生物支架及其人造卵巢和用途
US11607537B2 (en) 2017-12-05 2023-03-21 Virginia Tech Intellectual Properties, Inc. Method for treating neurological disorders, including tumors, with electroporation
US11925405B2 (en) 2018-03-13 2024-03-12 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
US11311329B2 (en) 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
US11950835B2 (en) 2019-06-28 2024-04-09 Virginia Tech Intellectual Properties, Inc. Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy
TW202233828A (zh) 2020-11-12 2022-09-01 日商Ａｄｅｋａ股份有限公司 去細胞化組織組成物
US11998662B1 (en) 2021-06-09 2024-06-04 Reprise Biomedical, Inc. Biologic matrix for a wound site and related methods
TW202306575A (zh) 2021-06-23 2023-02-16 日商Ａｄｅｋａ股份有限公司 去細胞化細胞結構體

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5567612A (en) * 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
CA1340581C (fr) 1986-11-20 1999-06-08 Joseph P. Vacanti Neomorphogenese chimerique d'organes par implatation cellulaire controlee, utilisant des matrices artificielles
US5106949A (en) 1989-09-15 1992-04-21 Organogenesis, Inc. Collagen compositions and methods for preparation thereof
WO1993007913A1 (fr) * 1991-10-24 1993-04-29 Children's Medical Center Corporation Neomorphogenese in vivo de structures urologiques a partir de cultures de cellules
US5581833A (en) 1994-11-04 1996-12-10 Zenoff; Andrew R. Support pillow with lumbar support for use in nursing and other applications
US5855610A (en) 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
WO1999022781A2 (fr) 1997-10-31 1999-05-14 Children's Medical Center Corporation Reconstruction de la vessie
FR2779340B1 (fr) 1998-06-04 2000-12-29 Delab Dispositif intraluminal implantable
ES2323662T3 (es) * 1998-06-05 2009-07-22 Organogenesis Inc. Protesis de injerto vascular producidas por bioingenieria.
US6428802B1 (en) * 1999-12-29 2002-08-06 Children's Medical Center Corp. Preparing artificial organs by forming polylayers of different cell populations on a substrate
AU2002343738A1 (en) * 2001-11-15 2003-05-26 University Of Medicine And Dentistry Of New Jersey A three-dimensional matrix for producing living tissue equivalents
BR0214212A (pt) * 2001-11-16 2004-10-26 Childrens Medical Center Criação de órgãos reprodutores femininos construìdos por tecido

Also Published As

Publication number Publication date
US20050208026A1 (en) 2005-09-22
JP4065846B2 (ja) 2008-03-26
US20030096406A1 (en) 2003-05-22
EP1448247B1 (fr) 2011-02-16
US7429490B2 (en) 2008-09-30
HK1077524A1 (en) 2006-02-17
JP2005514971A (ja) 2005-05-26
WO2003043675A1 (fr) 2003-05-30
US20030096407A1 (en) 2003-05-22
US7049057B2 (en) 2006-05-23
CN1962858A (zh) 2007-05-16
DE60239217D1 (de) 2011-03-31
AU2002343749B2 (en) 2007-07-12
CN1615161A (zh) 2005-05-11
US7806937B2 (en) 2010-10-05
EP1448247A1 (fr) 2004-08-25
CA2467558A1 (fr) 2003-05-30
BR0214212A (pt) 2004-10-26
AU2002343749A1 (en) 2003-06-10
CA2467558C (fr) 2009-07-14
KR20050044498A (ko) 2005-05-12
CN1294996C (zh) 2007-01-17

Similar Documents

Publication Publication Date Title
ATE498415T1 (de) Erzeugung gewebetechnologisch hergestellter weiblicher fortpflanzungsorgane
CROSBY et al. Embryology of the Müllerian duct system: review of present-day theory
Pack et al. The Age and Sex Distribution and Incidence of Neoplastic Diseases at the Memorial Hospital, New York City: With Comments on “Cancer Ages”
COUNSELLER Congenital absence of the vagina
Besenfelder et al. A method for endoscopic embryo collection and transfer in the rabbit
Belleannée et al. Cytologic findings in a neovagina created with Vecchietti’s technique for treating vaginal aplasia
MXPA04004539A (es) Creacion de organos reproductores femeninos con tejidos manipulados.
Spence Vaginal and uterine anomalies in the pediatric and adolescent patient
Anspach Gynecology
Belstra Intrauterine (transcervical) and fixed-time artificial insemination in swine
CN204542323U (zh) 可视化胚胎移植装置
RU2683694C1 (ru) Способ лечения воспалительных заболеваний придатков матки
Whitely et al. Split-thickness skin graft technique in the correction of congenital or acquired vaginal atresia
Ayre Cyclic ovarian changes in artificial vaginal mucosa
Fotopoulou et al. Reconstructive surgical management of cryptomenorrhea because of complex uterovaginal malformations with duplicate uterus and complete vaginal agenesis
CN206080775U (zh) 宫颈管防狭窄器
Bhargava Textbook of Gynaecology
WO2018233509A1 (fr) Médicament abortif
Hol et al. A prospective study to compare levonogestrol intrauterine system and trans-cervical resection of endometrium for treatment of abnormal uterine bleeding
CN214857300U (zh) 一种新型宫腔止血、防粘连、通液复合装置
Kori et al. A Case Series of Uterine Prolapse in Pregnancy.
CN211555290U (zh) 一种用于女性妇科综合检查及训练的模型
CN210466975U (zh) 用于孕妇经阴道行子宫颈内口环扎术的操作模型
Caon Lectures 25 and 26: Reproductive System
John et al. Logy of gynaecology

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties